Comparison of Two Types of Bowel Preparation for Inpatient Colonoscopy
Bowel preparation is a crucial step prior to colonoscopy to help with the optimal assessment of the colonic mucosa. Inadequate bowel preparation increases the length of the procedure, and is associated with decreased lesional detection rates. The ideal bowel preparation formulation should be able to completely clean the bowel, without leaving solid or liquid residues, and without modifying the mucosal appearance.
Bowel preparation may be administered in hospitalised patients or in the ER. Patients have less control on their environment and the intake of the bowel preparation. For example, there may be a delay in pharmacy delivery or inadequate supervision by the treating personnel. Hospitalised patients have more comorbidities, are usually less autonomous and mobile - both can add to the barriers leading to an adequate bowel preparation. Multiple studies have identified hospitalization status as an independent risk factor for poor bowel preparation.
The objective of this study is to access which bowel preparation regimen, between PEG 3350 with electrolytes 2L the day before and 2L the day of the colonoscopy vs bisacodyl + PEG 3350 with electrolytes 1L the day before and 1L the day of the colonoscopy, results in the cleanest bowel preparation in hospitalised patients.
연구 개요
상태
정황
연구 유형
등록 (실제)
단계
- 4단계
연락처 및 위치
연구 장소
-
-
Quebec
-
Montreal, Quebec, 캐나다, H3G1A4
- McGill University Health Centre
-
Sherbrooke, Quebec, 캐나다, J1G 2E8
- Centre Hospitalier Universitaire de Sherbrooke
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria
- 18 years or older
- Be able to comprehend the trial and provide written informed consent in French or English, or a close relative with power of attorney
- Have a recognised indication for full colonoscopy after evaluation by a gastroenterologist or surgeon
- Be hospitalized or in the ED of a participating hospital center.
- Need to receive a bowel preparation during hospitalization or the ED stay.
- Be able to complete the follow-up patient response form in French or English
Exclusion Criteria:
- Patient refusal
- A suspected or diagnosed bowel obstruction
- A toxic megacolon
- Ileus
- Decompensated heart failure
- Severe acute renal failure
- Severe electrolyte imbalance
- Previous bowel preparation in the last 7 days
- Pregnancy
- Time of randomization before 9h00 or after 22h00
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: PEG electrolytes 2L/2L split dose
|
Polyethylene glycol 17gm X 4 At 18h00 the day prior the colonoscopy, dilute 2 sachets in 2 L of water and drink 240 mL every 10 minutes On the day of the procedure, 4-5 hours prior the colonoscopy, dilute 2 sachets in 2 L of water and drink 240 mL every 10 minutes
|
|
활성 비교기: Bisacodyl 15 mg and PEG/electrolytes 1L/1L split dose
|
Bisacodyl 15 mg x 3 At 14h00 the day prior the endoscopic procedure: take 3 tablets of Bisacodyl ER (15 mg) orally then 5 hr later: PEG/electrolytes 1L/1L Polyethylene glycol 17gm Dilute one sachet of Polyethylene glycol 17gm in 1 L of water Start drinking at around 19h00 the night prior the colonoscopy Drink 240 ml every 10 minutes The day of the colonoscopy. At (4 hrs prior the procedure). Dilute on sachet of PEG and drink 240 ml every 10 minutes |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Efficacy
기간: following colonoscopy
|
Which bowel preparation regimen, between PEG 3350 with electrolytes 2L the day before and 2L the day of the colonoscopy vs bisacodyl + PEG 3350 with electrolytes 1L the day before and 1L the day of the colonoscopy, results in the cleanest bowel preparation in hospitalised patients.
|
following colonoscopy
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Tolerability
기간: Before colonoscopy
|
A questionnaire will be used to assess which is the most tolerable and acceptable to patients between the two bowel preparation regimens
|
Before colonoscopy
|
|
Clinical quality standards
기간: After colonoscopy
|
Does the bowel preparation given prior to in-hospital colonoscopy result in an excellent or good preparation rate that falls within the required clinical quality standards?
|
After colonoscopy
|
|
Cecal/ileal intubation rate
기간: Following colonoscopy
|
What is the cecal/ileal intubation rate for colonoscopies performed in hospitalized patients?
|
Following colonoscopy
|
|
Polyp detection rate
기간: Following colonosopy
|
What is the polyp detection rate for colonoscopies performed in hospitalized patients?
|
Following colonosopy
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
PEG/electrolytes 2L/2L split dose에 대한 임상 시험
-
Pharmbio Korea Co., Ltd.아직 모집하지 않음장 질환 | 대장 질환
-
Changhai HospitalTongji Hospital; Qilu Hospital of Shandong University; First Affiliated Hospital of Zhejiang... 그리고 다른 협력자들완전한
-
Shandong UniversityQianfoshan Hospital; Binzhou People's Hospital완전한
-
Sichuan UniversityAffiliated Hospital of North Sichuan Medical College; Affiliated Hospital of Southwest Medical...완전한